Peter Hohenstein - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Peter Hohenstein

Showing results (61-70 of 65) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 65 results.

The Journal of Clinical Investigation|March 5, 2014

Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophyThomas M Wishart, Chantal A Mutsaers, Markus Riessland, et al.

Nature Genetics|February 2, 2026

Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signalingAnagha Krishna, Alison Meynert, Karamjit Singh Dolt, et al.

Cell Reports. Medicine|February 16, 2023

OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.

Nature Communications|July 21, 2019

Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populationsRocío Rojo, Anna Raper, Derya D Ozdemir, et al.

Nature Genetics|March 11, 2008

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.

Pageof 7

Search research articles

Showing results (61-70 of 65) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 65 results.

The Journal of Clinical Investigation|March 5, 2014

Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophyThomas M Wishart, Chantal A Mutsaers, Markus Riessland, et al.

Nature Genetics|February 2, 2026

Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signalingAnagha Krishna, Alison Meynert, Karamjit Singh Dolt, et al.

Cell Reports. Medicine|February 16, 2023

OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.

Nature Communications|July 21, 2019

Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populationsRocío Rojo, Anna Raper, Derya D Ozdemir, et al.

Nature Genetics|March 11, 2008

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.

Pageof 7